M. Olson

发表

Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia

T. Kadia, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia & lymphoma.

A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma

B. Hill, J. Kaiser, Anson Snow, 2022, Leukemia & lymphoma.

Letermovir discontinuation at D+100 after Allogeneic Stem Cell Transplant is associated with increased CMV-related mortality.

F. Gao, R. Vij, P. Westervelt, 2022, Transplantation and cellular therapy.

The use of ruxolitinib for acute graft‐versus‐host disease developing after solid organ transplantation

J. Dipersio, M. Jacobs, D. Byers, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.